Data / Form D filings / Eqalix, Inc.
Eqalix, Inc.: Form D filings
Eqalix, Inc., a biotechnology company in Reston, VA, filed 3 Form D notices with the SEC between 2011 and 2012. The latest, on June 8, 2012, reports an offering of $500,000 with nothing sold yet.
Find out what Eqalix, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1900 CAMPUS COMMONS DRIVE, SUITE 100, Reston, VA, 20191
- Phone
- (703) 766-5749
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Virginia
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1528110
The full lists. Form D filings in Virginia: 771 rows, $38.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 8, 2012 | Amendment | $500,000 | $0 | $500,000 | 0 | Yet to occur | sec.gov |
| Jun 5, 2012 | New notice | $500,000 | $0 | $500,000 | 0 | Yet to occur | sec.gov |
| Aug 16, 2011 | New notice | $75,000 | $25,000 | $50,000 | 1 | Aug 5, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph P Connell | Executive Officer, Director, Promoter | |
| Reinhard P Koenig, MD | Promoter | |
| Sven P Rohmann, MD, Phd | Director |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Jun 4, 2012 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Eqalix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.